Bupleurum Species

Scientific Evaluation and Clinical Applications
CRC Press
  • 1. Auflage
  • |
  • erscheint ca. am 30. Juni 2020
  • Buch
  • |
  • Softcover
  • |
  • 272 Seiten
978-0-367-45366-4 (ISBN)
"The prominence of the Bupleurum species cannot be overstated. Across China and Japan, it serves as a main or supplementary ingredient in over two thirds of traditional medications. For over 2000 years, it has been used to treat fevers, intestinal maladies, malaria, and countless other afflictions. Modern research indicates that it may possess anti-tumor qualities, and researchers continue to report its impact on a wide range of ailments, from hepatitis and epilepsy, to irregularity and menopause, as well as psychosis and schizophrenia.Bupleurum Species: Scientific Evaluation and Clinical Applications brings together the work of leading researchers from Asia and Europe who examine this remarkable genus of plants. Providing a comprehensive look at all aspects relevant to the species, this historic volume- q
  • Englisch
  • London
  • |
  • Großbritannien
Taylor & Francis Ltd
  • Für höhere Schule und Studium
  • Höhe: 254 mm
  • |
  • Breite: 178 mm
978-0-367-45366-4 (9780367453664)
weitere Ausgaben werden ermittelt
Sheng-Li Pan is a professor in the Department of Pharmacognosy, School of Pharmacy, Fudan University, Shanghai, People's Republic of China. He studies aspects of Traditional Chinese Medicine (TCM), including identification of components, chemical constituents, pharmacological effects, and mechanism of action. He has discovered and published six new species in the genus Bupleurum. He received the Academic Award from Shanghai Health Bureau in 1985, the Academic Award from Chinese TCM Ministry in 1996, and the Advanced Award on Science and Technology from the Scientific and Technical Ministry of China in 1997.
Botany. Cultivation. Chemistry. Pharmacology. Patents.

Noch nicht erschienen

66,96 €
inkl. 7% MwSt.